Senores Pharma shares rose 3.7 per cent on BSE, logging an intraday high at Rs 572 per share. The stock was in demand after board approved the acquisition of 8,454 shares of Havix which aggregates to 3.73 per cent...
Drugmakers Mallinckrodt, Endo in talks to merge, source says
Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the matter told Reuters on Wednesday. A deal could likely be announced as soon as Thursday, the...
Syngene International shares in focus on acquiring first US biologics facility for $36.5 million
Shares of Syngene International will be in focus on Tuesday after the company announced that it acquired its first biologics facility in the United States from Emergent Manufacturing Operations Baltimore, a unit of...
Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mn
Sun Pharmaceuticals announced that it is set to acquire Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $355 million. The transaction is expected to be completed in the second calendar...
Senores Pharma to acquire 14 ANDAs from Dr Reddy’s Laboratories
Gujarat-based Senores Pharmaceuticals on Tuesday said it will acquire a basket of 14 Abbreviated New Drug Applications from Dr Reddy’s Laboratories for an undisclosed amount. Senores Pharmaceuticals, Inc, USA, a...
Glenmark acquires Acetylcysteine injection, launches in US market
Glenmark Pharmaceuticals Ltd on Monday said it has acquired generic version of Acetylcysteine injection from Aspen Pharma USA Inc for an undisclosed sum and launched the same in the US market. The acquisition by...
Aurobindo Pharma acquires 80% stake in Tergene Biotech
Aurobindo Pharma has completed the acquisition of 80% stake in Tergene Biotech, a step-down subsidiary of the company and also a joint venture company, held by Auro Vaccines, a wholly owned stepdown subsidiary of the...
Sandoz Family to Sell $2.9 Billion Stake in Novartis
Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group. The Sandoz Family Foundation, through the vehicle Emasan AG, is offering 26.5 million shares via an accelerated...
MO Alts acquires majority stake in Megafine Pharma for Rs 460 crore
Motilal Oswal Alternate Investment Advisors (MO Alts) has announced its first sole control investment, acquiring a majority stake (over 60 per cent) in Megafine Pharma, a Mumbai-based export-focused Active...
Motilal Oswal PE arm buys majority stake in bulk drug maker Megafine for ₹460 crore
The alternative investment arm of Motilal Oswal Financial Services Ltd has acquired a majority stake in export-focused bulk drug maker Megafine Pharma Ltd for ₹460 crore, betting on its growth as global companies look...
Felix Pharmaceuticals seeks $200-250mn for controlling stake in pet drug subsidiary, Felix Generics, amid booming market
Felix Pharmaceuticals is looking to sell a controlling stake in its subsidiary, Felix Generics, which makes veterinary drugs for ‘companion pets’ such as dogs and cats, three people with knowledge of the development...
Granules acquires Swiss firm for Rs 192 cr; forays into CDMO space
Drug firm Granules India on Friday said it has acquired Switzerland-based CDMO firm Senn Chemicals AG for CHF 20 million (around Rs 192 crore). Senn develops and manufactures, Peptides and Peptides-based applications...